📈 Jumpstart Signal Watchlist — June 08, 2026

🏢 What they do: Exelixis is an oncology-focused biotechnology company that discovers, develops, and commercializes medicines for hard-to-treat cancers. Its main products include CABOMETYX (cabozantinib), COMETRIQ (cabozantinib), and COTELLIC (cobimetinib), and it also advances a pipeline of small molecules and biotherapeutics for cancer treatment.
- 🎯 Current $51.74 is 2% below 3yr high $52.70 · ⏳ SMA200 $42.90 (current price $51.74 is above) · 💰 Market Cap $13.1B
- EXEL shows decent technicals supported by positive sentiment.

💎 Quality (Q): 53/60
- 🏦 Low drawdown (12.6% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 44% (>20%); ROE 43% (>15%); Low LT D/E 0.00 (<1.0).
⏰ Entry (E): 2/20
- 🔔 VWMA trending up (5 consecutive days)
📢 Sentiment (S): 6/10
- 🗞️ News sentiment is positive (mixed coverage).
✅ Norges Bank Makes New Investment in Exelixis, Inc. $EXEL — MarketBeat.
🤖 The article reports that Norges Bank initiated a large new position in Exelixis, a supportive signal from a major institutional investor. It also notes the stock near its 52-week high, reinforcing the positive tone.
✅ Exelixis (EXEL) Up 6% Since Last Earnings Report: Can It Continue? — Zacks Equity Research.
🤖 This article frames Exelixis as having gained since its last earnings report and asks whether the move can continue, which is generally constructive for the stock. Because it is commentary rather than new fundamentals, the bullish impact is moderate.
❌ Bank of New York Mellon Corp Cuts Position in Exelixis, Inc. $EXEL — MarketBeat.
🤖 This filing-style report says Bank of New York Mellon reduced its Exelixis position. The stock was also trading lower in the piece, which makes the item mildly negative for sentiment.
❌ Commonwealth Equity Services LLC Sells 259,643 Shares of Exelixis, Inc. $EXEL — MarketBeat.
🤖 The article reports that Commonwealth Equity Services trimmed its Exelixis stake, which is usually viewed as a negative ownership signal. It contains no offsetting company-specific catalyst to improve the tone.
🍭 Bonus (B): 10/10 — Biological Products (Biotech sector)

🏢 What they do: A10 Networks is an American public company specializing in application delivery controllers and cybersecurity solutions for on-premises, cloud, and edge environments. The company provides software and hardware products that secure applications, networks, and infrastructure from cyber threats while optimizing performance and availability across hybrid cloud architectures.
- 🎯 Current $30.98 is 5% below 3yr high $32.64 · ⏳ SMA200 $20.60 (current price $30.98 is above) · 💰 Market Cap $2.2B
- ATEN passed all filters and shows favorable conditions.

💎 Quality (Q): 55/60
- 🏦 Low drawdown (9.5% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 31% (>20%); ROE 20% (>15%); Low LT D/E 0.99 (<1.0).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA50 (13.1%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 62 showing strength
📢 Sentiment (S): 5/10
- 🗞️ News sentiment is neutral.
⚪️ A10 Networks, Inc. $ATEN Stock Position Decreased by Hillsdale Investment Management Inc. — MarketBeat.
🤖 This filing-based article reports that Hillsdale Investment Management reduced its ATEN position in a prior quarter. It is company-specific but does not indicate a clear operational improvement or deterioration for A10 Networks' business or stock.
🍭 Bonus (B): 10/10 — Computer Communications Equipment (Technology sector)

🏢 What they do: Dana Incorporated makes drivetrain and propulsion systems for vehicles, including axles, driveshafts, transmission-related components, and electrified propulsion systems. Its products are used in light vehicles and commercial vehicles, across conventional, hybrid, and electric powertrains.
- 🎯 Current $36.67 is 6% below 3yr high $38.93 · ⏳ SMA200 $27.49 (current price $36.67 is above) · 💰 Market Cap $4.0B
- DAN shows decent technicals supported by positive sentiment.

💎 Quality (Q): 47/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 5718% (>20%); ROE 59% (>15%); Low LT D/E 0.44 (<1.0); Near-high ROE setup (52wk high + ROE).
⏰ Entry (E): 5/20
- 🔔 VWMA trending up (5 consecutive days)
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive.
✅ RBC Capital raises Dana stock price target to $41 on RAM win — Investing.com.
🤖 RBC Capital increased its price target on Dana to $41 from $40 and kept an Outperform rating. A higher target and reiterated bullish stance are positive signals for DAN.
🍭 Bonus (B): 0/10 — Motor Vehicle Parts

🏢 What they do: CBL & Associates Properties, Inc. (CBL) is a real estate investment trust (REIT) that owns and manages a national portfolio of retail properties, including enclosed malls, outlet centers, lifestyle centers, and open-air centers across 20 states. The company focuses on active management, leasing, redevelopment, and creating integrated shopping experiences with retail, dining, and entertainment.
- 🎯 Current $48.01 is 1% below 3yr high $48.49 · ⏳ SMA200 $36.73 (current price $48.01 is above) · 💰 Market Cap $1.5B
- CBL shows decent technicals supported by positive sentiment.

💎 Quality (Q): 54/60
- 🏦 Low drawdown (10.6% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 448% (>20%); Revenue growth 19% (>15%); ROE 44% (>15%).
⏰ Entry (E): 0/20
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 60 showing strength
📢 Sentiment (S): 8/10
- 🗞️ News sentiment is positive.
✅ LADENBURG THALM/SH SH Stock Recommendations & Analyst ... — MarketBeat.
🤖 The snippet indicates a price target increase for CBL from $50.00 to $52.00 with a Buy rating dated 5/12/2026. An upward target revision and Buy stance are generally supportive for the stock.
⚪️ CBL Associates Properties (CBL) Stock Forecast & Price Target — Investing.com.
🤖 This page only reports analyst price-target consensus for CBL and does not describe a specific new company event or operating update. It is a market outlook item rather than substantive news, so its impact on the stock is neutral.
🍭 Bonus (B): 0/10 — REITs

🏢 What they do: Flotek Industries, Inc. is a chemistry and data analytics company serving the energy industry, especially oil and gas. It develops and markets specialty chemicals, logistics, and technology services along with real-time data analytics equipment and services to help customers improve efficiency, reduce costs, and lower environmental impact.
- 🎯 Current $23.55 is 5% below 3yr high $24.82 · ⏳ SMA200 $16.31 (current price $23.55 is above) · 💰 Market Cap $852M
- FTK shows decent technicals supported by positive sentiment.

💎 Quality (Q): 48/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; Revenue growth 27% (>15%); ROE 25% (>15%); Low LT D/E 0.34 (<1.0); Near-high ROE setup (52wk high + ROE).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA21 (12.9%)
- 🔔 Strong above EMA50 (23.7%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 68 showing strength
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive.
✅ Earnings call transcript: Flotek Industries sees robust Q1 2026 growth in data analytics — Investing.com.
🤖 Flotek reported robust Q1 2026 growth in its data analytics business, and the stock rose 6.14% in aftermarket trading after the results. That combination of strong operating performance and a positive market reaction is favorable for $FTK.
🍭 Bonus (B): 0/10 — Misc Chemical Products